VNS Therapy Programming System, Rx Only, Model 3000, v1.0.2.2
FDA Recall Z-2572-2018 · Posted None
Advertisement
Recalling FirmLivaNova USA Inc
Recall StatusTerminated
Product CodeLYJ
Date Initiated2018-01-24
Date Terminated2023-11-29
Product Quantity243 devices total
Reason for Recall
Unintended warning message displayed on generators programmed with a Model 3000 v.1.0.2.2 programmer.
Firm Action
Consignees were notified on about 01/24/2018 via URGENT: MEDICAL DEVICE CORRECTION letter. Instructions for physicians with new devices (interrogated for the first time) include to 1) apply the changes and proceed with programming as usual. The warning message requires a mandatory action to Apply Changes. After applying changes, therapy will automatically be programmed to 0 mA. The device may be immediately programmed back on to re-enable therapy. 2) To complete and return the attached Customer Response Form (by fax to (281) 853-1248 or by email to [email protected].
Instructions to physicians with devices that have been implanted (previously interrogated) include 1) Restore the normal and magnet mode stimulation parameters from the Summary screen immediately after the warning message screen. If desired, additional programming changes may be made. 2) For AutoStim (M106 only), detection must be re-enabled first, prior to re-enabling
AutoStim therapy. The previous AutoStim parameters are not retained and must be reentered manually. If needed, the previous parameters may be found by ending the session and viewing the Session Report for the generator. 3) Please complete and return the attached Customer Response Form by fax to (281) 853-1248 or by email to [email protected].
Additionally customers were instructed to ensure that this notice is communicated to all relevant personnel within the organization. For questions regarding the information in the letter, please contact Clinical Technical Support
at (866) 882-8804 (Monday to Friday, 8 AM to 5 PM CST) or e-mail at [email protected].
Root Cause
Software design (manufacturing process)
Distribution Pattern
Distributed domestically to AZ, CA, GA, IA, IL, IN, MO, MT, NC, NY, PA, SD, TN, TX, WA, WI.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement